Carvolix company profile
Carvolix develops AI- and imaging-guided mini-robotic technologies for structural heart and ischemic stroke procedures. Its portfolio includes Tavipilot, Artedrone, Mitrapilot and biomimetic valve assets, with financing tied to U.S. commercialization and regulatory development.
Facts
- Segment: Healthcare
- Country: France
- Founded: 2011
- Website: https://www.carvolix.eu/
Profile sections
- Summary
- Market context
- Facts
- Funding
- Investors
- Events
- Sources
Summary
Carvolix develops AI- and imaging-guided mini-robotic technologies for structural heart and ischemic stroke procedures. Its portfolio includes Tavipilot, Artedrone, Mitrapilot and biomimetic valve assets, with financing tied to U. S. commercialization and regulatory development.
Market context
Tavipilot Carvolix develops supervised-autonomy mini-robotic systems for interventional cardiology and neurovascular procedures.
Facts
- Website: https://www.carvolix.eu/
- HQ: Aix-en-Provence, France
- Founded: 2011
- Segment: Healthcare
- Known funding rounds: 1
Funding
- 2026-06-24 - Financing tranche - $11M - Carvolix secures new €10 million financing tranche - source: eqs-news.com
Investors
- Existing shareholders - Participant - Angel / Individual - 1 funding event - first seen 2026-06-24
- Truffle Capital - Participant - Vc - 1 funding event - first seen 2026-06-24
Events
- 2026-06-24 - Funding - Carvolix secures new €10 million financing tranche - The reserved offering issues 2,976,190 new ordinary shares at €3.36 per share to existing shareholders.
Carvolix canonical Korthos profile